Lotiglipron
A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Pfizer · Phase 1 · Terminated · Enrollment 16
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Period 1 | n/r | n/r | n/r | n/r |
| Period 2 | n/r | n/r | n/r | n/r |
| Period 3 | n/r | n/r | n/r | n/r |
| Period 4 | n/r | n/r | n/r | n/r |
| Period 5 | n/r | n/r | n/r | n/r |
| Period 6 | n/r | n/r | n/r | n/r |
| Period 7 | n/r | n/r | n/r | n/r |
| Period 8 | n/r | n/r | n/r | n/r |
Not shown
- Period 1: endpoint not reported
- Period 2: endpoint not reported
- Period 3: endpoint not reported
- Period 4: endpoint not reported
- Period 5: endpoint not reported
- Period 6: endpoint not reported
- Period 7: endpoint not reported
- Period 8: endpoint not reported